Ultrasonographical assessment of implanted biodegradable device for long-term slow release of methotrexate into the vitreous.

[1]  Marwan F. Al-Rjoub,et al.  Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.

[2]  R. Banerjee,et al.  Development of chitosan and polylactic acid based methotrexate intravitreal micro-implants to treat primary intraocular lymphoma: an in vitro study. , 2014, Journal of biomechanical engineering.

[3]  Chi-Chao Chan,et al.  Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma. , 2013, Discovery medicine.

[4]  R. Banerjee,et al.  Investigation of Kinetics of Methotrexate for Therapeutic Treatment of Intraocular Lymphoma , 2010, Current eye research.

[5]  A. A. Camacho,et al.  Rabbits' eye globe sonographic biometry. , 2010, Veterinary ophthalmology.

[6]  T. Siegal,et al.  Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience , 2008, British Journal of Ophthalmology.

[7]  J. Pulido,et al.  Intraocular methotrexate in ocular diseases other than primary central nervous system lymphoma. , 2006, American journal of ophthalmology.

[8]  M. Mochizuki,et al.  Ultrasound biomicroscopic study of sclelotomy sites after implantation of sustained release drug devices , 2002, The British journal of ophthalmology.

[9]  I. García,et al.  Review of ocular ultrasonography. , 2001, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

[10]  R. Nussenblatt,et al.  Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma. , 2001, Archives of ophthalmology.

[11]  L. Ambrosio,et al.  Biocompatibility and biodegradation of intravitreal hyaluronan implants in rabbits. , 2001, Biomaterials.